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CONSENT TO PARTICIPATION IN RESEARCH 
 
 
Name of Research Project: 
Ascertainment, diagnostic evaluation and gene mapping of South Australian families with possible 




Associate Professor Jozef Gecz 
Dr Zahiya Al Raisi 
Professor Eric Haan 
 
 
I,￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿  consent to my/my 
child￿s involvement in the above research project. I acknowledge that the nature, purpose and 
likely effects of the research project, especially as far as they affect me/my child, have been fully 
explained to my satisfaction by ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿... and my consent 
is given voluntarily. 
 
1.  I have been provided with an Information Sheet, and have had the opportunity to ask 
questions. I am satisfied with the explanations that I have been given and understand the 
information provided. 
 
2.  I have had the opportunity to discuss taking part in this research project with a family 
member or friend and /or have had the opportunity to have a family member or friend 
present whilst the research project was being explained by the researcher. 
 
3.  I consent to participate knowing that the aim of the research is to try to identify the gene 
change causing the intellectual disability in my family. 
 
4.  I understand that I/my child may not directly benefit by taking part in this study. 
 
5.  I acknowledge that the possible risks and /or side effects, discomforts and inconveniences, 
as outlined in the Information Sheet, have been explained to me. 
 
6.  I consent to the collection and storage of the health information that I will provide and of 
other relevant medical information about me/my child from medical records held by the SA 
Clinical Genetics Service, hospitals and other health professionals if necessary. 
 
7.  a)   I consent to a blood specimen being collected from me/my child so that my/my child￿s 
genetic material (DNA) can be obtained, stored and tested as part of the above project. 
I understand that no undertaking is made regarding the availability or suitability of the 
sample for subsequent use by me or my family.  
 
b)   I do/do not consent to the blood sample being used in any other research  
      Project, provided the project has the approval of the Women￿s & Children￿s   
      Hospital Research Ethics Committee. 
  
8.  I understand that the proposed genetic studies have the potential to confirm or exclude 
paternity and maternity, but that research participants will not be informed if non-paternity 
or non-maternity is found. 
 
9.  I understand that I can withdraw (my child) from the study at any stage and that this will 
not affect medical care or any other aspects of my/my child￿s relationship with this hospital. 
 
10.  I understand that the researchers will inform me about the outcome of the research, 
whether or not it is successful in identifying the gene change causing the intellectual 
disability in my family. 
 
11.  I understand that I/my child be provided with the results of the studies done on me/my child. 
 
12.  I understand that if the research is successful, it may lead to other research in the future 
that may have implication for other family members, including my children. 
 
13.  I understand that while information gained in the study may be published, I/my child will not 
be identified and information will be confidential. 
 
14.  I am aware that I should retain a copy of the completed Consent Form and Information 
Sheet. 
 




￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿..￿￿￿￿.....     ￿￿￿.￿￿￿￿￿..￿￿￿￿￿￿￿￿￿￿￿￿..￿￿￿￿ 
Name of research participant                               Name of witness 
 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿..￿￿.￿￿.     ￿￿￿￿￿￿￿￿￿.￿￿￿￿￿￿..￿￿￿￿..￿￿￿￿￿ 
Signature of research participant                          Signature of witness 
 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿....￿￿￿     ￿￿￿￿￿￿￿￿￿￿..￿￿￿￿￿￿￿￿..￿￿￿.￿￿￿ 




I certify that I have explained the study to the parent/patient and/or child and consider that 
he/she understands what is involved. 
 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿..￿￿￿....     ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿.￿￿￿￿￿.. 
Signature                                                          Date 
 
 































































Name of Research Project: 
Ascertainment, diagnostic evaluation and gene mapping of South Australian families with 




Associate Professor Jozef Gecz 
Dr Zahiya Al Raisi  
Professor Eric Haan 
 
 
You are invited to take part in this research study because it is possible that there is a change 
in a gene on the X-chromosome that is responsible for intellectual disability in your family. The 
research will try to work out where the gene is on the X-chromosome and to identify the gene.  
 
Your involvement in this study is entirely voluntary, and you are free to withdraw from the 
study at any time. You do not have to give any reason if you do not wish to participate or if you 
wish to withdraw. Your medical care will not be affected if you decide not to participate. 
 
All affected and some unaffected family members will be invited to participate in the study. 
 
Participation will involve providing health information and the collection of a blood sample. 
 
Someone experienced in blood taking will collect the blood sample (20 ml, about four 
teaspoonfuls) from one of your veins. This may involve some mild discomfort or bruising. The 
blood sample can be taken at the Women￿s & Children￿s Hospital, through your general 
practitioner, or at one of the many blood collection centres throughout South Australia. 
Arrangements can be made for blood collection elsewhere in Australia if necessary.  
 
The blood for the study will be sent to the Department of Genetic Medicine at the Women￿s & 
Children￿s Hospital, Adelaide.  
•  The genetic material (DNA) will be extracted from the blood and stored frozen until it is used 
for the research. Once frozen, the DNA will keep indefinitely.  
•  Part of some blood samples will be treated in a way that will allow the white cells to keep 
their ability to divide, and to provide more DNA in the future if needed. 
•  If initial studies are not successful in identifying the gene change, the stored DNA may be re-
tested in the future to try again to identify it.  
•  Some DNA samples may be sent to our international collaborators to screen for the gene 
changes using the latest technologies.  
•  The amount of DNA obtained from each person￿s blood sample should be sufficient for the 
whole research study. 
 
The research may take a long time to complete (some studies like this one have taken several 
years) and may not be successful. 
  
The research requires participation of several members of your family. We will not approach 
your relatives without your consent or the consent of another family member who is 
participating in the research. You may be asked to make the first contact with a relative to ask 
whether he or she agrees to be contacted by us. If consent is given, we will then make contact 
to explain the research in detail and to seek his or her consent to participation. 
 
We will let you know the outcome of the attempt to map the gene, whether it is successful or 
not. 
 
It is likely that most participants will not receive any direct personal benefit from the research. 
 
For most participants, the research will not produce information about you that is not already 
known from your health history and how you are related to the other members of the family. 
However some family members who do not have intellectual disability and whose children do 
not have it may be shown to have a high chance of carrying the gene mutation even though it 
has not caused any problems. This would be unexpected information and could mean that 
unborn children or grand children could inherit the gene mutation and have intellectual 
disability.  
 
If the research generates information about you that may be of relevance to the health of other 
family members, such as your children (e.g. that they might have inherited the intellectual 
disability gene mutation), your consent will be sought before offering to disclose such 
information to the family members concerned. 
 
Non-paternity or non-maternity is the situation in which someone considered to be a person￿s 
biological mother or father is not his or her real mother or father. Most genetic tests cannot 
determine this. However, when genetic tests are done on several members of one family, as in 
this research study, they might reveal non-paternity or non-maternity if it is present. If non-
paternity or non ￿maternity is detected, we will not disclose it to anyone unless required to do 
so by law. 
 
Any personal information we collect about you during the study and any results that come from 
the study will be kept confidential.  No information that could lead to identification of any 
individual will be released without his or her written consent, unless we are required to do so by 
law.  However, your DNA and health information will be used and stored in a way that allows to 
us to know whose DNA or health information it is ￿ in other words, it will be possible to link 
your name and other personal details to your DNA sample and health information.  
 
This study has been approved by the Research Ethics Committee of the Women￿s & Children￿s 
Hospital. Should you wish to discuss the study with someone not directly involved, particularly if 
you have any complaints or concerns, you should contact the Executive Secretary of the 
Committee, Ms Brenda Penny, at the Women￿s & Children￿s  Hospital on 81616521. 
 
If you have any questions or concerns about the study at anytime after reading this information 
sheet, you should contact Dr Zahiya Al Raisi or Professor Eric Haan on (08) 8161 7375 during 






















































 XLMRForm  page 1 ot () 
X Linked Mental Retardation 

Research Study Family No: 
Surname: 
Given Names:  Sex:  Male  Female 
Hospital URS:  GF: 
PKNo:  DNA No: 
Address:  DOB: 




Mother's Details  Father's Details 

Surname:  Surname: 

Given Names:  Given Names: 

Age:  Years  Months  Age:  Years  Months 
Race:  Caucasian  Aboriginal  Race:  Caucasian  Aboriginal 
Asian  Other  Asian  Other 
Consanguinity:  Yes  No 
Plurality:  Single  Twin  Triplet  Quad  Other 
Pregnancy Outcomes:  Live births 
Spontaneous abortions 





















Family HlO Autism:  Yes  No 
If  yes, specifY: ..................................................................................................................................... . 
Family HIO Epilepsy:  Yes  No 
Ifyes, specifY: .....................................................................................................................................  . 
Family H/O Other Neurological Problems:  Yes  No 
Ifyes, specifY: .....................................................................................................................................  .. 
CLINICAL  __lN~ORMATION_~F~_~TIIE____ AFFECTEI) 
MEMBER: ----------_.-."­
Birth wt  gms 
Birth Head Circumference  em 
Birth Height  em 
Neonatal Problems  Yes  No 
Ifyes specifY .......................................................................................................................................................  .. 
MR severity:  Borderline  Mild  Moderate  Severe  Profound 
filc:IIC:\Users\zahiya\Documcnts\za\XLMR Forml.htm  23/03/2009 XLMRForm  Page 3 01'6 
IQ: 
Specific delays or learning difficulties:  Yes  No 
If  yes, 
specifY ...................................................................................................................................................... . 
DD Assessment:  - Clinical  Yes  No 
Years  Months Ifyes,  Age: 
Result  .................................................................................................................................  . 
- Psychological  Yes  No 
Years  Months If  yes, Age: 
How? .................................................................................................................................  . 

Result. ................................................................................................................................  . 
Pervasive developmental disorder:  Yes  No 
Ifyes, specifY: ............................................................................................................  . 
Epilepsy:  Yes  No 
Ifyes, specifY: ............................................................................................................ . 
Psychiatric Disorders:  Yes  No 
Ifyes, specifY: ............................................................................................................  . 
Abnormal behavioural features  Yes  No 
If  yes, specifY: ............................................................................................................ . 
Birth Defects:  Yes  No 
If  yes, specifY: ............................................................................................................  . 
Vision  Normal  Impaired 
If  impaired, specifY: ................................................................................................. .. 
Hearing:  Normal  Impaired 
If  impaired, specifY: ................................................................................................. .. 
Other Neurological Features:  Yes  No 
Ifyes, specifY: ............................................................................................................  . 
Current Weight:  Kg 
23/03/2009 file:IIC:\Users\zahiya\Documents\za\XLMR Forml.htm XLMRForm  Page 4 of6 
Current Height:  cm 
Current Head Circumference:  cm 
Dysmorphic Facies  Yes  No 
Ifyes, specify: ............................................................................................................ . 
Other Dysmorphic Features  Yes  No 
If  yes,  specify: 
Malformations:  Yes  No 
If  yes, specify: ............................................................................................................ . 
Neurological Signs:  Yes  No 
Ifyes, specify: ............................................................................................................ .. 

Other Findings: ..............................................................................................................................................................  . 

Routine cytogenetics before 1991 





Fragile X (A) molecular test 
Fragile X (A) cytogenetic test 
Fragile X (E) molecular test 
ARX 
Microdeletion 17q21.31 ( devries) 
Copy number other imbalances (devries) 
MECP2 
PQBPI 









Array-BACIPAC tiling path (Belgium) 

Array-Sequencing chip Affymetric (Germany) 


















Haemoglobin H bodies 
Uric acid 
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